Watchlist Price Alert

BridgeBio Pharma Inc. (BBIO)

NASDAQ: BBIO · Real-Time Price · USD

44.54

2.37 (5.61%)

At close: Jun 24, 2025, 3:59 PM

44.46

-0.18%

After-hours: Jun 24, 2025, 07:58 PM EDT

BridgeBio Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	681.1M	375.94M	376.69M	393.77M	356.08M	363.77M	436.09M	92M
Short-Term Investments	n/a	58.95M	95.23M	442.89M	251.01M	182.22M	n/a	n/a
Long-Term Investments	143.75M	n/a	43.65M	49.15M	2.6M	31.14M	17.05M	381K
Other Long-Term Assets	18.2M	22.63M	20.22M	33.03M	21.33M	-4.86M	1.09M	92K
Receivables	4.72M	1.75M	17.08M	19.75M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	37.93M	-68.9M	n/a	n/a	n/a	n/a
Other Current Assets	34.87M	27.65M	37.93M	177K	35.73M	22.63M	n/a	889K
Total Current Assets	720.69M	477.59M	505.2M	839.71M	642.82M	599.77M	445.22M	97.13M
Property-Plant & Equipment	12.78M	19.84M	25.25M	45.97M	36.83M	5.63M	1.57M	440K
Goodwill & Intangibles	23.93M	26.32M	28.71M	44.93M	n/a	n/a	n/a	n/a
Total Long-Term Assets	198.65M	68.79M	117.84M	173.08M	60.76M	31.91M	19.72M	913K
Total Assets	919.34M	546.38M	623.04M	1.01B	703.59M	631.68M	464.94M	98.04M
Account Payables	9.62M	10.65M	11.56M	11.88M	8.95M	8.85M	13.51M	1.89M
Deferred Revenue	14.6M	6.1M	8.16M	n/a	75.9M	31.45M	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	1.46M	n/a	n/a	n/a
Other Current Liabilities	130.18M	65.59M	66.78M	1.5M	9.55M	4.08M	4.01M	997K
Total Current Liabilities	154.4M	143.84M	117.75M	130.13M	91.85M	52.38M	32.58M	8.55M
Long-Term Debt	1.72B	1.73B	1.71B	1.7B	475.86M	91.79M	54.51M	143.87M
Other Long-Term Liabilities	479.38M	9.36M	26.64M	22.07M	9.52M	3.53M	479.36M	312K
Total Long-Term Liabilities	2.22B	1.75B	1.75B	1.75B	503.85M	103.32M	533.87M	144.18M
Total Liabilities	2.38B	1.89B	1.87B	1.88B	595.7M	155.7M	566.44M	152.73M
Total Debt	1.73B	1.74B	1.72B	1.73B	495.79M	99.79M	54.51M	143.87M
Common Stock	196K	181K	157K	154K	125K	124K	6.59M	3.41M
Retained Earnings	-3.1B	-2.56B	-1.92B	-1.44B	-888.75M	-440.03M	-170.58M	-61.43M
Comprehensive Income	8K	31K	-328K	-132K	192K	254K	-231K	-27K
Shareholders Equity	-1.46B	-1.35B	-1.25B	-870.41M	57.91M	408.45M	-163.99M	-58.02M
Total Investments	143.75M	58.95M	138.89M	492.04M	251.01M	182.22M	17.05M	381K